XPO1 and lymphoma: Importantly, the presence of the XPO1E571K mutation is associated with favorable prognosis in lymphoma patients [10] as this mutation alters nuclear export signal recognition in a sequence-specific manner and enhances cellular sensitivity to therapeutic agents targeting XPO1 protein function currently under clinical development [31].